Asaf Alperovitz

CEO
Biopharmaceuticals
Allium Medical 
Israel

Business Expert Clinical Sciences
Biography

 Mr. Asaf Alperovitz served as the Chief Financial Officer of Syneron Medical Ltd. (NASDAQ: ELOS) from 2010 to 2012. Prior to that, he was the Israeli Site Manager and Chief Financial Officer of Omrix Biopharmaceuticals, Inc. From 2005 to 2008 he served as the Chief Financial Officer of Tefron Ltd. From 2003 to 2005, Asaf was the Chief Financial Officer of Corigin Ltd., an enterprise Software Company. Asaf held various management positions in the high-tech area of Ernst & Young, both in Israel and in California for eight years including the management of the Israeli Desk of Ernst & Young in California

Research Intrest

Asaf Alperovitz has a strong background as a public company Chief Financial Officer, including relevant experience with three global companies. Mr. Alperovitz is a Certified Public Accountant and holds a Bachelor's degree in Accounting and Economics and a Masters in Business Administration from Tel Aviv University.

Global Scientific Words in Clinical Sciences